Yahoo · Sep 4, 2026
Should Investors Buy IRTC as Growth Improves but Risks Stay Elevated?
iRhythm's Q2 revenue growth, margin expansion and record free cash flow strengthen its case, but reimbursement and regulatory risks remain elevated.
IR
NASDAQ · IRTC
iRhythm Technologies, Inc
Healthcare · Medical - Devices
$112.88
Down-$2.30 (-2.04%)
Updated Sep 11, 2026, 4:08 PM
SID Score
4.2/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 5.45B
- P/E ratio
- -105.69
- Dividend yield
- 0.00%
- 52-week range
- $100.85 – $212.00
- Volume
- 727.31K
- Avg. volume
- 425.37K
Price performance
IRTC price history
1M range · 0 trading sessions · Daily adjusted prices
IRTC does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
Latest IRTC news
The latest Smart Investors Daily articles mentioning IRTC.
Stock researchCompany · Overview
IRTC research
Overview
Company profile and research snapshot.
Company profile
iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $210.80
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 18, 2026 | Wells Fargo | Overweight | — |
| Aug 10, 2026 | Truist Securities | Buy | — |
| Aug 7, 2026 | Needham | Buy | — |
| Aug 7, 2026 | Wells Fargo | Overweight | — |
| Aug 7, 2026 | Evercore ISI Group | Outperform | — |
News briefing
No generated briefing is available yet.
Yahoo · Sep 4, 2026
Smart Wearable ECG Monitors Market Size, Share & Trends Analysis, Global Forecast to 2036. Market Growth from $2.4B (2026) to $6.4B by 2036, Profiles Apple, AliveCor, iRhythm, Philips, and 12 Other Key Players
317-Page Report Maps Patch, Smartwatch, and Handheld ECG Devices as Regulatory Clearances and AI-Powered Arrhythmia Detection Reshape Cardiac Monitoring Outside the ClinicDublin, Sept. 04, 2026 (GLOBE NEWSWIRE) -- The "Smart Wearable ECG Monitors Market Size, Share & Trends Analysis, - Global Forecast to 2036" has been added to ResearchAndMarkets.com's offering. Market Size and Forecast The global smart wearable ECG monitors market is estimated to be valued at USD 2.4 billion in 2026 and is proj
Yahoo · Aug 26, 2026
iRhythm Holdings to Participate in Wells Fargo 21st Annual Healthcare Conference
SAN FRANCISCO, Aug. 26, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today announced that it will participate in the upcoming Wells Fargo 21st Annual Healthcare Conference. iRhythm’s management is scheduled to present on Wednesday, September 9, 2026, at 8:45 a.m. ET. Interested parties may access a live and archived webcast of the fireside chat on the “Events
Yahoo · Aug 26, 2026
iRhythm Holdings (IRTC) Faces An Audit Committee Shift As Its Undervalued Narrative Holds
iRhythm Holdings (IRTC) informed investors that Board member and Audit Committee chair Brian Yoor resigned for personal reasons on August 12, 2026. Existing director Karen McGinnis will step in to chair the Audit Committee. iRhythm Holdings’ share price has been volatile over 2026, with a 30 day share price return of 12.72% and a 7 day gain of 6.81%. However, the year to date share price return is down 29.75% and the 1 year total shareholder return is down 26.74%, even though the 5 year total...
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
